Medication info
Ciclo Tablet (Acyclovir)

Ciclo Tablet (Acyclovir)

Prescription medicationTablet
Ingredient · strength
Acyclovir›200mg / 1 tablet
Manufacturer / importer
Vivozon Pharmaceutical Co., Ltd.
Appearance
Light blue round tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 199201002 · Notified 1992.01.28 · Insurance code 658200680

Summary

Main use
Treatment of herpes zoster; treatment and prevention of herpes simplex (genital herpes, etc.); treatment of chickenpox
Who uses it
Adults · Children
Adult dosage
Treatment of herpes simplex virus infections: Administer 200 mg of acyclovir per dose 5 times daily at 4-hour intervals for 5 days. Treatment may be extended for severe initial infections. In patients with severe immunocompromise (such as after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per dose or the route of administration may be changed to intravenous injection. Administer as soon as possible after infection; for recurrent infections, administration is preferably started at the first appearance of prodromal symptoms or lesions. Prevention of herpes simplex infections in patients with normal immune function: Administer 200 mg of this medicine per dose 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg per dose may be administered 2 times daily at 12-hour intervals. The dose may then be reduced to 200 mg per dose 2 ~ 3 times daily after confirming its effectiveness. To assess the natural course of the disease, long-term treatment should be interrupted periodically every 6 ~ 12 months. Prevention of herpes simplex infections in immunocompromised patients: Administer 200 mg of this medicine per dose 4 times daily at approximately 6-hour intervals. In patients with severe immunocompromise (such as after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per dose or the route of administration may be changed to intravenous injection. Administer during the period of risk of infection. Treatment of herpes zoster: Administer 800 mg of this medicine per dose 5 times daily at approximately 4-hour intervals, except at bedtime, for a total of 7 days. For patients with severe immunocompromise or gastrointestinal malabsorption, intravenous administration should be considered. Administer as soon as possible after infection; the earlier treatment is started, the better the effect. Patients with renal impairment are more likely to experience neuropsychiatric adverse reactions; use caution, for example by extending the dosing interval or reducing the dose. Patients with renal impairment - Treatment of herpes simplex infections: The oral dose is generally not higher than the amount accumulated with intravenous administration. However, for patients with severe renal impairment (creatinine clearance less than 10 mL per minute), administration of 200 mg of this medicine every 12 hours is recommended. Patients with renal impairment - Treatment of herpes zoster virus infections: For patients with creatinine clearance less than 10 mL per minute, dose reduction to 800 mg per dose 2 times daily at approximately 12-hour intervals is recommended. Patients with renal impairment - Treatment of herpes zoster virus infections: For patients with creatinine clearance of 10 ~ 25 mL per minute, dose reduction to 800 mg per dose 3 times daily at approximately 8-hour intervals is recommended.
Children's dosage
Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients - 2 years and older: Same as adults. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients - Under 2 years: Administer 1/2 of the adult dose. There are no definitive data on the prevention of herpes simplex virus infections in patients with normal immune function. Treatment of chickenpox in children 2 years and older: Administer 20 mg per kg of body weight per dose (maximum 800 mg per dose) 4 times daily for 5 days. Treatment should be started as soon as possible after the chickenpox rash appears, preferably within 24 hours of rash onset.

Ingredients

Manufacturer
Vivozon Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of herpes zoster; treatment and prevention of herpes simplex (genital herpes, etc.); treatment of chickenpox

  • Primary genital herpes
  • recurrent genital herpes
  • skin simplex herpes virus infection
  • mucosal tissue simplex herpes virus infection
  • shingles virus infection
  • acute shingles pain
  • chickenpox
View approved original text

This medicine is used to treat and prevent infections caused by the simplex herpes virus, including initial and recurrent genital herpes, and skin and mucosal tissue infections. It is also effective in relieving acute pain of shingles virus infections, particularly useful in the early treatment. However, efficacy for postherpetic neuralgia has not yet been clearly proven. This medication can also be used for the treatment of chickenpox in children aged 2 years and older. Overall, this drug is used to treat viral infections such as simplex herpes, shingles, and chickenpox and to improve symptoms.

Dosage and Administration

Adult dosage

Treatment of herpes simplex virus infections: Administer 200 mg of acyclovir per dose 5 times daily at 4-hour intervals for 5 days. Treatment may be extended for severe initial infections. In patients with severe immunocompromise (such as after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per dose or the route of administration may be changed to intravenous injection. Administer as soon as possible after infection; for recurrent infections, administration is preferably started at the first appearance of prodromal symptoms or lesions. Prevention of herpes simplex infections in patients with normal immune function: Administer 200 mg of this medicine per dose 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg per dose may be administered 2 times daily at 12-hour intervals. The dose may then be reduced to 200 mg per dose 2 ~ 3 times daily after confirming its effectiveness. To assess the natural course of the disease, long-term treatment should be interrupted periodically every 6 ~ 12 months. Prevention of herpes simplex infections in immunocompromised patients: Administer 200 mg of this medicine per dose 4 times daily at approximately 6-hour intervals. In patients with severe immunocompromise (such as after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per dose or the route of administration may be changed to intravenous injection. Administer during the period of risk of infection. Treatment of herpes zoster: Administer 800 mg of this medicine per dose 5 times daily at approximately 4-hour intervals, except at bedtime, for a total of 7 days. For patients with severe immunocompromise or gastrointestinal malabsorption, intravenous administration should be considered. Administer as soon as possible after infection; the earlier treatment is started, the better the effect. Patients with renal impairment are more likely to experience neuropsychiatric adverse reactions; use caution, for example by extending the dosing interval or reducing the dose. Patients with renal impairment - Treatment of herpes simplex infections: The oral dose is generally not higher than the amount accumulated with intravenous administration. However, for patients with severe renal impairment (creatinine clearance less than 10 mL per minute), administration of 200 mg of this medicine every 12 hours is recommended. Patients with renal impairment - Treatment of herpes zoster virus infections: For patients with creatinine clearance less than 10 mL per minute, dose reduction to 800 mg per dose 2 times daily at approximately 12-hour intervals is recommended. Patients with renal impairment - Treatment of herpes zoster virus infections: For patients with creatinine clearance of 10 ~ 25 mL per minute, dose reduction to 800 mg per dose 3 times daily at approximately 8-hour intervals is recommended.

Children's dosage

Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients - 2 years and older: Same as adults. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients - Under 2 years: Administer 1/2 of the adult dose. There are no definitive data on the prevention of herpes simplex virus infections in patients with normal immune function. Treatment of chickenpox in children 2 years and older: Administer 20 mg per kg of body weight per dose (maximum 800 mg per dose) 4 times daily for 5 days. Treatment should be started as soon as possible after the chickenpox rash appears, preferably within 24 hours of rash onset.

Precautions

This drug contains acyclovir and should not be administered to certain patients. Patients who have had hypersensitivity to this drug or any of its components, or to valacyclovir, should not use it. Caution is required when administering to patients with impaired renal function as they are at higher risk of neurological adverse reactions. Patients with impaired liver function should be administered cautiously as liver function may deteriorate. In infants or children, it should be used minimally and only when necessary, and caution should be exercised for elderly patients as they may experience more side effects due to decreased renal function. During the use of this drug, it is possible to rarely experience anaphylactic shock or severe hypersensitivity reactions, so if symptoms like low blood pressure, difficulty breathing, or chest tightness occur, administration must be stopped immediately and medical personnel should be informed. Disorders such as rash, fever, blisters, hives, alopecia, severe skin diseases may occur, so if any unusual symptoms appear, stop use and seek appropriate treatment. Neurological effects can occur, leading to altered consciousness, confusion, hallucinations, convulsions, drowsiness, anxiety, and these symptoms may occur more frequently in elderly patients or those with impaired renal function. As it can burden the kidneys, careful monitoring for renal-related abnormal symptoms, such as renal failure or hematuria, should be conducted. Various side effects have been reported, including blood and lymphatic abnormalities, liver function abnormalities, gastrointestinal symptoms, musculoskeletal pain, cardiovascular issues, urinary problems, therefore, if symptoms occur, consult medical personnel immediately. This drug is most effective when administered early in the course of the illness, so it is important to start treatment as soon as symptoms appear. Maintain adequate hydration during the treatment period to reduce the risk of dehydration and renal toxicity. Caution is required for hazardous activities such as driving or operating machinery due to potential altered consciousness. Drug interactions may occur when taken with other medications, so be sure to inform medical personnel of any medications being taken. Pregnant women or those who may become pregnant should only take this drug if the benefits outweigh the risks, and breastfeeding must be suspended during treatment. In cases of overdose, severe neurological symptoms or kidney damage may occur, so immediate medical assistance should be sought, and procedures such as dialysis may be needed if necessary. High-dose administration of this drug may affect genetic abnormalities or reproductive function; however, no such effects have been reported within recommended dosages.

Side effects

  • Anaphylactic shock
  • anaphylactoid reaction
  • hypotension
  • dyspnea
  • feeling of chest tightness
  • photosensitivity reaction
  • fixed drug eruption
  • rash
  • fever
  • vesicles
Show 117 more
  • urticarial erythema
  • urticaria
  • alopecia
  • erythema multiforme
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • altered consciousness
  • disorientation
  • impaired concentration
  • aggressive behavior
  • depersonalization
  • anxiety
  • akinesia
  • coma
  • confusion
  • delirium
  • stuttering
  • encephalopathy
  • hallucinations
  • psychosis
  • seizures
  • drowsiness
  • tremors
  • agitation
  • amnesia
  • insomnia
  • anxiety
  • soliloquy
  • paresthesia
  • ataxia
  • inability to walk
  • involuntary movement
  • nystagmus
  • renal failure
  • crystalluria
  • elevated BUN
  • increased serum creatinine
  • hematuria
  • proteinuria
  • red blood cell casts in urine
  • pyuria
  • leukocyte destruction vasculitis
  • lymphadenopathy
  • bleeding
  • purpura
  • anemia
  • leukopenia
  • leukocytosis
  • eosinophilia
  • lymphocytosis
  • thrombocytosis
  • granulocytopenia
  • thrombocytopenia
  • basophilia
  • hepatitis
  • liver dysfunction
  • jaundice
  • abnormal liver function tests
  • hepatomegaly
  • gastritis
  • thirst
  • constipation
  • acute pancreatitis
  • diarrhea
  • loose stools
  • upper abdominal pain
  • gastric pain
  • abdominal pain
  • nausea
  • vomiting
  • dyspepsia
  • loss of appetite
  • glossitis
  • fever
  • peripheral edema
  • syncope
  • pallor
  • muscle weakness
  • malaise
  • generalized fatigue
  • headache
  • arthralgia
  • myalgia
  • arrhythmia
  • chest pain
  • hypertension
  • hypotension
  • tachycardia
  • palpitations
  • urinary obstruction
  • dysuria
  • glycosuria
  • pneumonia
  • pharyngitis
  • pleural effusion
  • pain
  • hearing loss
  • conjunctivitis
  • visual disturbances
  • taste disturbances
  • alopecia
  • sweating
  • hyponatremia
  • decreased serum protein levels
  • elevated total cholesterol levels
  • elevated triglyceride levels
  • increased serum potassium levels
  • decreased serum albumin levels
  • anxiety
  • coma
  • seizures
  • somnolence
  • confusion
  • hallucinations
  • agitation
  • epileptic seizure
  • stupor

Not everyone experiences these, and they can vary from person to person.

Storage

This drug is sensitive to light and should be stored in a container that blocks light. Additionally, to safely store the medication, it is recommended to keep it at room temperature, ideally not too hot or too cold.

Appearance and packaging

Appearance

Light blue round tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.